Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Jeffrey Sum-Lung Wong"'
Autor:
Vikki Tang, Jeffrey Sum Lung Wong, Gerry Gin Wai Kwok, Bryan Cho Wing Li, Ka Wing Ma, Wong Hoi She, Chung Mau Lo
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 2 (2021)
Background Programmed cell death protein 1 (PD-1) pathway blockade with immune checkpoint inhibitors (ICIs) is a standard therapy in advanced hepatocellular carcinoma (HCC) nowadays. No strategies to overcome ICI resistance have been described. We ai
Externí odkaz:
https://doaj.org/article/5f87dbb432394523851e4b34b6953f4a
Autor:
Tsun-Ho LAM, Jeffrey Sum-Lung WONG, Chun-Ka WONG, Gerry Gin Wai KWOK, Miaochang ZHOU, Benjamin Yu-Fai SO, Ian Yu-Hin LEUNG, Hung-Fat TSE
Publikováno v:
Journal of the Hong Kong College of Cardiology. 29:135-142
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8340dbec0fbcc23687b7ada82be8ea38
https://doi.org/10.55503/2790-6744.1484
https://doi.org/10.55503/2790-6744.1484
Publikováno v:
Hepatology Communications. 7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36f81acb4c6373fde6f1c50c2016fdfc
https://doi.org/10.1097/hc9.0000000000000117
https://doi.org/10.1097/hc9.0000000000000117
Autor:
Hiroto Kikuchi, Aya Matsui, Satoru Morita, Zohreh Amoozgar, Koetsu Inoue, Zhiping Ruan, Daniel Staiculescu, Jeffrey Sum-Lung Wong, Peigen Huang, Thomas Yau, Rakesh K Jain, Dan G Duda
Publikováno v:
J Natl Cancer Inst
Immune checkpoint blockade combined with antiangiogenic therapy induces vascular normalization and antitumor immunity and is efficacious in hepatocellular carcinoma (HCC); but whether and how initial immunotherapy affects the efficacy of subsequent a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd3937d0e38116765fd9f7a5d12bebab
https://doi.org/10.1093/jnci/djac051
https://doi.org/10.1093/jnci/djac051
Autor:
Tracy Cy Shum, Yawen Dong, Thomas W. Leung, Wong Hoi She, Bryan Cho Wing Li, Vikki Tang, Cynthia S Y Yeung, Thomas Yau, Jeffrey Sum Lung Wong, Gerry Gin-Wai Kwok, Josephine Tsang, Ka Wing Ma, Ada Law, Anna Tai, Joanne Chiu, Tan To Cheung, Roland Leung
Publikováno v:
Cancers
Volume 13
Issue 9
Cancers, Vol 13, Iss 2002, p 2002 (2021)
Volume 13
Issue 9
Cancers, Vol 13, Iss 2002, p 2002 (2021)
Simple Summary The vascular endothelial growth factor and c-MET pathways are strongly implicated in hepatocellular carcinoma (HCC). Cabozantinib inhibits both pathways and has been approved in sorafenib-exposed advanced HCC (aHCC). We aimed to evalua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ca9ffb8b43e9325dbc8cffb9d3bf489
http://europepmc.org/articles/PMC8122581
http://europepmc.org/articles/PMC8122581
Autor:
Roland Leung, Thomas Yau, Jeffrey Sum Lung Wong, Tan To Cheung, Joanne Chiu, Bryan Cho Wing Li, Josephine Tsang, Gerry Gin Wai Kwok
Publikováno v:
Expert review of gastroenterologyhepatology. 15(6)
The systemic treatment of advanced, unresectable hepatocellular carcinoma (HCC) has undergone an evolution in recent years. In March 2020, a combination of nivolumab and ipilimumab was approved by the FDA for treatment of patients with advanced HCC w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8060c9f5c9c8bf265e191c8b38684c8
https://pubmed.ncbi.nlm.nih.gov/33666530
https://pubmed.ncbi.nlm.nih.gov/33666530
Autor:
Yawen Dong, Tan To Cheung, Ada Law, Ka Wing Ma, Vikki Tang, Tracy Cy Shum, Roland Leung, Gin Wai Kwok, W.H. She, Thomas W.T. Leung, Anna Tai, Jeffrey Sum Lung Wong, Cynthia S Y Yeung, Joanne Wing Yan Chiu, Thomas Yau, Bryan Li, Wing Yan Josephine Tsang
Publikováno v:
Journal of Clinical Oncology. 39:e16179-e16179
e16179 Background: Cabozantinib is licensed for use as second- or third-line treatment for sorafenib-exposed advanced hepatocellular carcinoma (aHCC) based on the phase III CELESTIAL trial. However, its use in the post-immune checkpoint inhibitors (I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45d441696a4cb28a6be088075f6f37a9
https://doi.org/10.1200/jco.2021.39.15_suppl.e16179
https://doi.org/10.1200/jco.2021.39.15_suppl.e16179
Autor:
Jess L.C. Chan, Tan To Cheung, Gin Wai Kwok, Jeffrey Sum Lung Wong, Wai Meng David Tai, Joycelyn Jie Xin Lee, Su Pin Choo, Joanne Wing Yan Chiu, Thomas Yau, Bryan Li, Vikki Tang, Roland Leung, Wing Yan Josephine Tsang
Publikováno v:
Journal of Clinical Oncology. 39:e16181-e16181
e16181 Background: Immune checkpoint inhibitors (ICIs) and tyrosine kinase inhibitors (TKIs) are widely adopted in contemporary advanced HCC (aHCC) treatment algorithms. Nevertheless, the optimal strategy for treatment after ICI exposure is unknown.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf4be4e5b35b4d8bb549f32367a5b2c9
https://doi.org/10.1200/jco.2021.39.15_suppl.e16181
https://doi.org/10.1200/jco.2021.39.15_suppl.e16181
Autor:
Wing Yan Josephine Tsang, Gin Wai Kwok, Thomas Yau, Bryan Li, Tan To Cheung, Ka Wing Ma, Jeffrey Sum Lung Wong, W.H. She, Vikki Tang, Roland Leung, Joanne Wing Yan Chiu
Publikováno v:
Journal of Clinical Oncology. 39:e16184-e16184
e16184 Background: Hepatic derangement commonly accompanies advanced HCC (aHCC) and limits the use of systemic therapies. We aimed to evaluate the use of single agent anti-PD-1 nivolumab or pembrolizumab in Child-Pugh (CP) grade B or C patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2cb23ae9f656d733b8ae24d35118edbe
https://doi.org/10.1200/jco.2021.39.15_suppl.e16184
https://doi.org/10.1200/jco.2021.39.15_suppl.e16184
Autor:
Ryohichi Sugimura, Jeffrey Sum Lung Wong, Thomas Yau, Roland Leung, Joanne Wing Yan Chiu, Yawen Dong, Bryan Cho Wing Li, Tan To Cheung, Gerry Gin Wai Kwok, Ka-On Lam
Publikováno v:
Cancers, Vol 13, Iss 1949, p 1949 (2021)
Cancers
Cancers
Simple Summary Hepatocellular carcinoma is an aggressive cancer with high mortality. The introduction of immune-checkpoint inhibitors (ICIs) targeting the programmed-cell death 1 pathway (PD-1/L1) has led to a paradigmatic change in the systemic trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8118f0b8992e1f5792c547cd52cb31fd
https://doi.org/10.3390/cancers13081949
https://doi.org/10.3390/cancers13081949